NMD4C and MDC Host Second SMA Outcome Measure Training Workshop for Physiotherapists and Occupational Therapists Across Canada
The Spinal Muscular Atrophy (SMA) Motor Function Measures workshop organized by the NMD4C in collaboration with MDC took place in Montreal, Quebec on December 3rd, 2024 and was a resounding success. This workshop was established to harmonize assessment practices for the following SMA outcome measures across Canada:
- Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders
- Bayley’s Scale of Infant & Toddler Development
- Adapted Test of Neuromuscular Disorders
- Hammersmith Motor Functional Scale – Expanded
- Revised Upper Limb Module
- 6 Minute Walk Test
- Patient Reported Outcome Measures for SMA
The workshop complemented the interactive training session that took place earlier this year for French-speaking physiotherapists and occupational therapists in Quebec City. This initiative was created to deliver essential training to clinicians (physiotherapists and occupational therapists), ensuring a consistent approach to evaluating motor function in children and adults with SMA.
Content co-designed and co-developed by (L to R) Dr. Cam-Tu Émilie Nguyen, Sarah Turgeon-Desilets, Melissa Dermody, Angela Chiu, Cheryl Scholtes, Allison Banks & Dorothy Drost
Therapists from the following provinces were in attendance: Ontario, Quebec, Alberta, British Columbia, New Brunswick, Nova Scotia, Saskatchewan & Manitoba. Post-event surveys reinforced that the participants highly valued the opportunity to attend in-person training, to network with colleagues across Canada, engage in productive discussions on outcome measures for SMA and gain knowledge on establishing a clinic for the adult SMA population. The workshop also featured insights from a patient partner with lived experience – Catherine Boivin, who shared her experiences with the outcome measure assessments.
A report summarizing both the French and English workshops is currently in creation and will be available soon. The content from this SMA outcome measures workshop will be used to create an online interactive training resource to provide access to this cutting-edge training to a broader audience.
If you are interested in receiving training resources, or to learn more about our work on outcome measures, please contact NMD4C Outcome Measures and Natural History Coordinator Zainab Adamji to learn how we can work together.
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.